SYK and systemic lupus erythematosus: The role of SYK in TLR signaling in B cells and pDCs could have significant implication for SYK inhibitors as therapeutic agents for SLE since the development and progression of the disease are believed to be driven by the inappropriate activation of TLR7, TLR8 and TLR9.